Brief: FDA Completes Inspection Of IND Swift Labs' API Manufacturing Facility At Derabassi, Punjab
March 13 (Reuters) - IND Swift Laboratories Ltd ISLB.NS :
* USFDA COMPLETES INSPECTION OF IND-SWIFT LABS API
MANUFACTURING
FACILITY AT DERABASSI, PUNJAB
* U.S. FDA CLEARED DERABASSI API FACILITY INSPECTION WITHOUT
ANY
483 OBSERVATION
Source text for Eikon: ID:nBSEDr10n
Further company coverage: ISLB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IND Swift Laboratories
See all newsBrief: Ind Swift Laboratories Upgrading Manufacturing Facility Located At J&K To EU-GMP/Pics Standards
Brief: Ind Swift Laboratories June-Quarter Consol Net PAT 246.8 Million Rupees
Brief: Ind Swift Laboratories Enters MoU With Him Infratech For Warehouse Construction On July 28, 2026
Brief: Ind Swift Laboratories To Consider Raising Of Funds By Way Of Issuance Of One Or More Instruments
Brief: Ind Swift Laboratories Says Tribunal Rejected All Claims Of PI Industries, Counterclaims Of Co, Others